Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as GBX 5 ($0.06) and last traded at GBX 10.87 ($0.14), with a volume of 788720 shares traded. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Stock Performance
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 196.67. The company has a market cap of £5.89 million, a PE ratio of -1.20 and a beta of -0.26. The firm’s 50-day simple moving average is GBX 18.15 and its two-hundred day simple moving average is GBX 22.27.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- Most Volatile Stocks, What Investors Need to Know
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Calculate Stock Profit
- Qualcomm Stock Is Coiling for a Breakout
- What is a Low P/E Ratio and What Does it Tell Investors?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
